![Albert Qin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 4 M $ as of 31/07/2026
Albert Qin is currently the Chief Medical Officer at PharmaEssentia Corp., a position held since 2017.
Formerly, Dr. Qin was an Executive Officer and Chief Scientific Officer at SymBio Pharmaceuticals Ltd.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARMAESSENTIA CORP. 0.03% | 28/02/2026 | 109,314 ( 0.03% ) | 4 M $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| PHARMAESSENTIA CORPORATION | Chief Tech/Sci/R&D Officer | 13/01/2017 |
| Companies | Position | End |
|---|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
SymBio Pharmaceuticals Ltd.
 SymBio Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutics for cancer and other related diseases | Health Technology |
PharmaEssentia Corp.
 PharmaEssentia Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells therapeutic products for the treatment of hematologic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
